Literature DB >> 15979763

Evidence for direct actions of melanocortin peptides on bone metabolism.

Laurence M Dumont1, C-S Jenny Wu, Michele A Tatnell, Jillian Cornish, Kathleen G Mountjoy.   

Abstract

Expression of melanocortin-4 receptor (MC4R) mRNA in developing rat limb buds, teeth, and skull bone first indicated a possible role for MC4R in bone metabolism. We therefore investigated whether MC4R mRNA was expressed in the rat osteosarcoma UMR106.06 cell line and in primary rat osteoblast cells. Reverse transcriptase-polymerase chain reaction (RT-PCR), Northern blot analysis, and ribonuclease protection assay (RPA) were used to demonstrate MC4R mRNA expression in UMR106.06 and primary osteoblast cells. MC4R mRNA was found to be localized to the periosteum of mouse bone using in situ hybridization. We also used RT-PCR and rat specific MC2R and MC5R oligonucleotides to amplify the correct size DNA fragments for these melanocortin receptors from rat primary osteoblasts. In conclusion, melanocortin receptor expression in mouse periosteum and rat osteoblasts suggests a direct role for POMC derived peptides in bone development and bone metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979763     DOI: 10.1016/j.peptides.2004.12.034

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.

Authors:  Markus Böhm; Susanne Grässel
Journal:  Endocr Rev       Date:  2012-06-26       Impact factor: 19.871

2.  Isolated skeletal malformations in a child with a small mosaic ring microduplication of 18 p11.21q11.2: genotype-phenotype correlations.

Authors:  Thomas P Slavin; Kevin Kuruvilla; Christine A Curtis; Laurie A Christ; Anna L Mitchell
Journal:  Am J Med Genet A       Date:  2011-02-22       Impact factor: 2.802

3.  Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass.

Authors:  Eva W Iepsen; Jinyi Zhang; Mette Hollensted; Sten Madsbad; Torben Hansen; Jens J Holst; Niklas R Jørgensen; Jens-Christian Holm; Signe S Torekov
Journal:  J Bone Miner Metab       Date:  2019-08-30       Impact factor: 2.626

4.  Therapeutic senescence via GPCR activation in synovial fibroblasts facilitates resolution of arthritis.

Authors:  Trinidad Montero-Melendez; Ai Nagano; Claude Chelala; Andrew Filer; Christopher D Buckley; Mauro Perretti
Journal:  Nat Commun       Date:  2020-02-06       Impact factor: 14.919

Review 5.  Non-Canonical Effects of ACTH: Insights Into Adrenal Insufficiency.

Authors:  Valeria Hasenmajer; Ilaria Bonaventura; Marianna Minnetti; Valentina Sada; Emilia Sbardella; Andrea M Isidori
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-19       Impact factor: 5.555

6.  Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3.

Authors:  Trinidad Montero-Melendez; Mila F M Madeira; Lucy V Norling; Asil Alsam; Michael A Curtis; Tarcília A da Silva; Mauro Perretti
Journal:  Am J Pathol       Date:  2014-06-27       Impact factor: 4.307

7.  Regulation of lean mass, bone mass, and exercise tolerance by the central melanocortin system.

Authors:  Theodore P Braun; Benjamin Orwoll; Xinxia Zhu; Peter R Levasseur; Marek Szumowski; My Linh T Nguyen; Mary L Bouxsein; Robert F Klein; Daniel L Marks
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  The Ay allele at the agouti locus reduces the size and alters the shape of the mandible in mice.

Authors:  Jun-ichi Suto
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

9.  Melanocortin 1 receptor-signaling deficiency results in an articular cartilage phenotype and accelerates pathogenesis of surgically induced murine osteoarthritis.

Authors:  Julia Lorenz; Elisabeth Seebach; Gerit Hackmayer; Carina Greth; Richard J Bauer; Kerstin Kleinschmidt; Dominik Bettenworth; Markus Böhm; Joachim Grifka; Susanne Grässel
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

Review 10.  Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.